Portfolio company
Combat
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company manufactures hyperthermic drug delivery devices for the treatment of bladder and peritoneal cancers in clinical patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Combat Medical
This company manufactures hyperthermic drug delivery systems for hospitals and oncology clinics to treat patients with bladder and peritoneal cancers.
HEPTA Medical
This company develops a microwave ablation platform with integrated temperature sensors for clinicians to treat early-stage lung cancer patients using minimally invasive procedures.
ArgoMed
This company develops water-induced thermotherapy devices for the non-surgical treatment of benign prostatic hyperplasia in male patients.
CureSign
This medical device company develops implantable sensors and data analytics to monitor cancer treatment efficacy for oncologists and clinical teams.
PHIRE
PHIRE develops a theranostic medical device that combines photoacoustic imaging with artificial intelligence to identify and treat bladder cancer for the medical community.
TRANSURETHRAL IMAGING & THERAPY
This company develops a transurethral ultrasound imaging and high-intensity focused ultrasound therapy system for urologists to treat prostate disease in outpatient procedures.
CG Oncology
This biopharmaceutical company develops oncolytic immunotherapies for patients with non-muscle invasive bladder cancer.
Emergence
This biopharmaceutical company develops antibody drug conjugates to treat high-need cancers including bladder and triple-negative breast cancer.
